Based on the Synlogic Inc stock forecast from 0 analysts, the average analyst target price for Synlogic Inc is not available over the next 12 months. Synlogic Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Synlogic Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Synlogic Inc’s stock price was USD 1.12. Synlogic Inc’s stock price has changed by -6.67% over the past week, +9.27% over the past month and -37.43% over the last year.
No recent analyst target price found for Synlogic Inc
No recent average analyst rating found for Synlogic Inc
Company Overview Synlogic Inc
Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts. Read Less
Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically abso...Read More
Frequently Asked Questions About Synlogic Inc (SYBX) Stock
Stock Target Advisor's fundamental analysis for Synlogic Inc's stock is Bearish.
Unfortunately we do not have enough data on SYBX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SYBX's stock to indicate what its average analyst target is.
SYBX stock's Price/Earning ratio is 25.80.
Our analysis grades SYBX stock's Price / Earning ratio at F. This means that SYBX stock's Price/Earning ratio is above 75% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this SYBX may be a overvalued for its sector.
The last closing price of SYBX's stock was USD 1.12.
The most recent market capitalization for SYBX is USD 0.01B.
Unfortunately we do not have enough analyst data on SYBX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Synlogic Inc's stock.
As per our most recent records Synlogic Inc has 1 Employees.
Synlogic Inc's registered address is PO Box 30, Winchester, MA, United States, 01890.
You can get more information about it from Synlogic Inc's website at https://www.synlogictx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Synlogic Inc (SYBX) Stock
Stock Target Advisor's fundamental analysis for Synlogic Inc's stock is Bearish.
Unfortunately we do not have enough data on SYBX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on SYBX's stock to indicate what its average analyst target is.
SYBX stock's Price/Earning ratio is 25.80.
Our analysis grades SYBX stock's Price / Earning ratio at F. This means that SYBX stock's Price/Earning ratio is above 75% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this SYBX may be a overvalued for its sector.
The last closing price of SYBX's stock was USD 1.12.
The most recent market capitalization for SYBX is USD 0.01B.
Unfortunately we do not have enough analyst data on SYBX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Synlogic Inc's stock.
As per our most recent records Synlogic Inc has 1 Employees.
Synlogic Inc's registered address is PO Box 30, Winchester, MA, United States, 01890.
You can get more information about it from Synlogic Inc's website at https://www.synlogictx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for SYBX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
